हिंदी में पढ़ें

Company

Nazara Technologies sees Q2 profit decline 33% to Rs 16 crore

Nazara Technologies sees Q2 profit decline 33% to Rs 16 crore

Fri, Nov 15, 2024

Nazara Technologies Q2 Results: Homegrown gaming and sports media company Nazara Technologies reported 33 per cent drop in its net profit for the July-September period (Q2 FY25).

Global Health Q2 Results: Net profit rises 5% to Rs 131 crore

Global Health Q2 Results: Net profit rises 5% to Rs 131 crore

Thu, Nov 14, 2024

Global Health Q2 Results: Global Health, which operates hospitals under the Medanta brand, on Thursday said its profit after tax increased 5 per cent to Rs 131 crore in the September 2024 quarter.

Glenmark Pharmaceuticals PAT at Rs 354.49 crore in September quarter

Glenmark Pharmaceuticals PAT at Rs 354.49 crore in September quarter

Thu, Nov 14, 2024

Glenmark Pharmaceuticals Ltd on Thursday reported a consolidated profit after tax of Rs 354.49 crore in the second quarter ended on September 30, 2024.

TRENDING NOW

Himadri Speciality Q2 PAT grows three-fold to Rs 100 crore

Himadri Speciality Q2 PAT grows three-fold to Rs 100 crore

Wed, Oct 18, 2023

Himadri Speciality Chemical Limited (HSCL) has posted nearly three-fold jump in consolidated profit after tax at Rs 100.62 crore for September quarter 2023-24, aided by reduced expenses.

IREDA sanctions Rs 180-cr term loan to Jagatjit Industries to set up ethanol plant in Punjab

IREDA sanctions Rs 180-cr term loan to Jagatjit Industries to set up ethanol plant in Punjab

Tue, Oct 17, 2023

State-owned IREDA has sanctioned a term loan of Rs 180 crore to Jagatjit Industries Ltd, which the company will utilise to set up an ethanol facility in Punjab. The total project investment is approximately Rs 210 crore, Jagatjit Industries Ltd (JIL) said in a statement.

Bajaj Finance to acquire 26% in Pennant Technologies for Rs 268 crore

Bajaj Finance to acquire 26% in Pennant Technologies for Rs 268 crore

Tue, Oct 17, 2023

Bajaj Finance, an NBFC arm of Bajaj Finserv, said the company entered into a binding term sheet with Pennant Technologies on October 16, 2023, for acquisition of up to 26 per cent stake in the latter.

Vedanta invites Japanese companies to partner in India's electronics manufacturing revolution

Vedanta invites Japanese companies to partner in India's electronics manufacturing revolution

Tue, Oct 17, 2023

Vedanta, a global natural resources and technology conglomerate, highlighted the tremendous investment opportunities in India, especially in Gujarat, and urged Japanese companies to partner in India's electronics manufacturing revolution.

Toshiba to go private on December 20 after successful $13 billion takeover bid

Toshiba to go private on December 20 after successful $13 billion takeover bid

Thu, Oct 12, 2023

The Japanese conglomerate Toshiba last month announced the success of a 2 trillion yen ($13.4 billion) tender offer from private equity firm Japan Industrial Partners.

China's Country Garden faces fresh debt payments, could announce restructuring soon

China's Country Garden faces fresh debt payments, could announce restructuring soon

Mon, Oct 09, 2023

China's average daily home sales based on floor area during the Golden Week holiday were down 17 per cent from a year ago, according to China Index Academy on Saturday.

Bristol-Myers Squibb to acquire Mirati in up to $5.8 billion deal

Bristol-Myers Squibb to acquire Mirati in up to $5.8 billion deal

Mon, Oct 09, 2023

Bristol is buying Mirati at a time when the shares are considerably cheaper than they were. Mirati's shares touched a 52-week high of $101.3 apiece on Nov. 28 and are now trading at $60.2.

ADIA to invest Rs 4,966.80 crore in Reliance Retail for 0.59% stake

ADIA to invest Rs 4,966.80 crore in Reliance Retail for 0.59% stake

Sat, Oct 07, 2023

"This investment values RRVL at a pre-money equity value of Rs 8.381 lakh crore (USD 100.83 billion), which makes it among the top four companies by equity value in the country," Reliance Industries said in a regulatory filing.

Strides Pharma gets USFDA nod to market HIV drug

Strides Pharma gets USFDA nod to market HIV drug

Wed, Oct 04, 2023

Strides Pharma Science said its subsidiary has received approval from the US health regulator to market a generic version of Gilead Sciences' Atripla tablets which are indicated to help control HIV infection.

NMDC's iron ore production rises 10% in September

NMDC's iron ore production rises 10% in September

Tue, Oct 03, 2023

State-owned miner NMDC Ltd on Tuesday posted a 9.8 per cent rise in iron ore production at 3 million tonnes (MT) in September. The company's iron ore output in September last year was 2.73 MT, NMDC said in a regulatory filing.

S&P Global Ratings cuts Vedanta Resources credit rating

S&P Global Ratings cuts Vedanta Resources credit rating

Sat, Sep 30, 2023

S&P Global Ratings on Friday cut the rating of billionaire Anil Agarwal's Vedanta Resources Ltd rating to 'CCC' from 'B-' and placed it under "creditwatch with negative implications".

Uno Minda to enhance stake in JV firm to 76%

Uno Minda to enhance stake in JV firm to 76%

Fri, Sep 29, 2023

The company's board has approved increasing stake in Minda Westport Technologies Ltd (MWTL) from 50 to 76 per cent by acquiring an additional 26 per cent stake from its joint venture partner Westport Fuel Systems Italia, Uno Minda said in a statement.

Accenture warns of weaker fiscal 2024 as IT spending remains under pressure

Accenture warns of weaker fiscal 2024 as IT spending remains under pressure

Thu, Sep 28, 2023

IT services firm Accenture forecast full-year earnings and first-quarter revenue below Wall Street targets, signaling that high inflation and interest rates pressures will hurt demand through next year.

JioAirFiber could unlock a US$7-10 billion revenue opportunity: Jefferies

JioAirFiber could unlock a US$7-10 billion revenue opportunity: Jefferies

Thu, Sep 28, 2023

JioAirFiber could unlock a US$7-10 billion revenue opportunity as it could spur broadband adoption among 85 million Pay-TV homes that do not have internet access today, according to a report by foreign brokerage Jefferies.

AbbVie terminates deal with I-Mab to develop cancer drug

AbbVie terminates deal with I-Mab to develop cancer drug

Sat, Sep 23, 2023

AbbVie's decision to scrap the deal comes after it pulled the plug on an early-stage study in August last year that was testing lemzoparlimab in combination with two other drugs for treating two types of blood cancers, myelodysplastic syndrome and acute myelocytic leukemia.

Median cost of IT outages at Indian firms now Rs 520 crore a year: Report

Median cost of IT outages at Indian firms now Rs 520 crore a year: Report

Wed, Sep 13, 2023

Although no respondents in India use just one single platform for observability, 51 per cent said they prefer a single, consolidated platform and highlighted too many monitoring tools as the biggest challenge to achieving full-stack observability.

6 Indian companies enter top 10 digital media players' list in FY23

6 Indian companies enter top 10 digital media players' list in FY23

Wed, Sep 06, 2023

The robust performance of the digital media market comprises various segments such as over-the-top (OTT) video services, audio streaming, short-form video platforms and digital gaming.

Emirates Global Aluminium's first-half profit slides 66%

Emirates Global Aluminium's first-half profit slides 66%

Thu, Aug 31, 2023

One of the world's largest aluminium producers, EGA posted net profit of 2 billion dirhams ($544.62 million) for the first six months of the year, down from 5.9 billion dirhams a year earlier.

Titagarh Rail Systems bags Rs 350-crore contract for Ahmedabad Metro project

Titagarh Rail Systems bags Rs 350-crore contract for Ahmedabad Metro project

Wed, Aug 30, 2023

Titagarh Ahmedabad Metro: Titagarh Rail Systems Ltd (TRL) formerly Titagarh Wagons said it has received a letter of acceptance for a Rs 350-crore contract from GMRC for the design, manufacture, supply, testing, commissioning, and training of 30 standard gauge cars.

Lupin gets USFDA nod to market generic drug

Lupin gets USFDA nod to market generic drug

Fri, Aug 25, 2023

Drug maker Lupin on Friday said it has received approval from the US health regulator to market a generic product, used in the treatment of a lung disease, in the American market.

Load More

LIVE TV

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x